Lv62
2800 积分 2024-01-12 加入
Long-Term Outcome of Anti–Glomerular Basement Membrane Antibody Disease Treated with Plasma Exchange and Immunosuppression
1个月前
已完结
Anti–Glomerular Basement Membrane Disease: Recent Updates
1个月前
已关闭
Autoimmunity in Anti–Glomerular Basement Membrane Disease: A Review of Mechanisms and Prospects for Immunotherapy
1个月前
已完结
Epidemiology, clinical features, risk factors, and outcomes in anti-glomerular basement membrane disease: A systematic review and meta-analysis
1个月前
已完结
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
2个月前
已完结
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
2个月前
已完结
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes
2个月前
已完结
Quételet (body mass) index and effects of dapagliflozin in chronic kidney disease
2个月前
已完结
Effect of Dapagliflozin on Cardiovascular Outcomes According to Baseline Kidney Function and Albuminuria Status in Patients With Type 2 Diabetes
2个月前
已完结
A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesity
3个月前
已完结
皖公网安备34019202002308
